NCT04735354View on ClinicalTrials.gov

Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction Patients: a Real World Study in India

CompletedOBSERVATIONAL
Enrollment

268

Participants

Timeline

Start Date

October 27, 2020

Primary Completion Date

June 1, 2022

Study Completion Date

June 1, 2022

Conditions
Heart Failure
Interventions
DRUG

sacubitril/valsartan

There was no treatment allocation. Patients administered sacubitril/valsartan by prescription that started before inclusion of the patient into the study were enrolled.

Trial Locations (1)

Unknown

Novartis Investigational Site, Mumbai

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY